FDA has issued a warning regarding potential cybersecurity risk with Medtronic’s MiniMed 508 insulin pump and MiniMed Paradigm insulin pumps. These insulin pumps wirelessly connect with blood glucose meter and continuous glucose monitor. Additionally, the remote controller and CareLink USB are also used with these pumps. FDA’s concern lies in the cybersecurity vulnerabilities identified in these pumps as potential for someone besides the person wearing the pump could wireless adjust the insulin pump settings leading to either high or low blood glucose. Medtronic is providing alternative insulin pumps with enhanced cybersecurity features. To learn more, please click below.
Please share your thoughts and subscribe to receive my blogs.
#FDA #cybersecurity #insulin #pump
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.